Company Description
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally.
The company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection, such as insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms.
It distributes its products through national distribution companies, buying groups, or co-operatives, as well as through sales offices, wholly owned distributors, sales force executives, and sales agents.
American Vanguard Corporation was incorporated in 1969 and is headquartered in Newport Beach, California.
| Country | United States |
| Founded | 1969 |
| Industry | Agricultural Inputs |
| Sector | Materials |
| Employees | 739 |
| CEO | Douglas Kaye |
Contact Details
Address: 4695 MacArthur Court Newport Beach, California 92660 United States | |
| Phone | 949 260 1200 |
| Website | american-vanguard.com |
Stock Details
| Ticker Symbol | AVD |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000005981 |
| CUSIP Number | 030371108 |
| ISIN Number | US0303711081 |
| Employer ID | 95-2588080 |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Douglas A. Kaye III CPA | Chairman and Chief Executive Officer |
| David T. Johnson C.F.A. | Chief Financial Officer |
| Timothy J. Donnelly Esq. | Chief Information Officer, General Counsel and Secretary |
| Shirin Khosravi | Chief Human Resource Officer |
| Jared Stanley | Senior Vice President of Supply Chain and Operations |
| Anthony Young | Director of Investor Relations |
| William A. Kuser | Director of Corporate Communications |
| Michael J. DiPaola | Senior Vice President of Strategy, Marketing and Research & Development |
| Nolteanous Gilliam | Senior Vice President of Manufacturing |
| Robert F. Gilbane | President of Gemchem Inc |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 26, 2026 | SCHEDULE 13G/A | Filing |
| Mar 19, 2026 | 8-K | Current Report |
| Mar 18, 2026 | 8-K | Current Report |
| Mar 16, 2026 | 10-K | Annual Report |
| Feb 13, 2026 | SCHEDULE 13G/A | Filing |
| Nov 12, 2025 | SCHEDULE 13G | Filing |
| Nov 12, 2025 | 8-K | Current Report |
| Nov 10, 2025 | 10-Q | Quarterly Report |
| Oct 30, 2025 | SCHEDULE 13G | Filing |
| Sep 4, 2025 | 144 | Filing |